2020
DOI: 10.1016/j.jormas.2019.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…84 A daily three-drug regimen is also effective for treating osteoradionecrosis; however, no studies to date have examined its effectiveness as a protective agent. 56,81,[95][96][97] Further RCTs are necessary to determine whether PENTOCLO also has a prophylactic role in supporting oncologic treatments.…”
Section: Pentoxifylline-tocopherol-clodronatementioning
confidence: 99%
“…84 A daily three-drug regimen is also effective for treating osteoradionecrosis; however, no studies to date have examined its effectiveness as a protective agent. 56,81,[95][96][97] Further RCTs are necessary to determine whether PENTOCLO also has a prophylactic role in supporting oncologic treatments.…”
Section: Pentoxifylline-tocopherol-clodronatementioning
confidence: 99%